BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24643127)

  • 1. Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment - data from ten years' observation at the Regional Centre of Pulmonology, Bydgoszcz, Poland.
    Przybylski G; Dąbrowska A; Trzcińska H
    Med Sci Monit; 2014 Mar; 20():444-53. PubMed ID: 24643127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    Matulyte E; Davidaviciene E; Kancauskiene Z; Diktanas S; Kausas A; Velyvyte D; Urboniene J; Lipnickiene V; Laurencikaite M; Danila E; Costagliola D; Matulionyte R
    PLoS One; 2023; 18(3):e0282046. PubMed ID: 36952578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis.
    Prado TN; Rajan JV; Miranda AE; Dias ED; Cosme LB; Possuelo LG; Sanchez MN; Golub JE; Riley LW; Maciel EL
    Braz J Infect Dis; 2017; 21(2):162-170. PubMed ID: 27936379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in Poland in 2017.
    Korzeniewska- Koseła M
    Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of socio-demographic, clinical characteristics and treatment outcomes of children with tuberculosis in Sindh, Pakistan.
    Laghari M; Sulaiman SAS; Khan AH; Memon N
    BMC Infect Dis; 2019 Jan; 19(1):82. PubMed ID: 30678656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.
    Nowiński A; Wesołowski S; Korzeniewska-Koseła M
    Front Public Health; 2023; 11():1253615. PubMed ID: 37732096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unemployment in TB patients - ten-year observation at regional center of pulmonology in Bydgoszcz, Poland.
    Przybylski G; Dabrowska A; Pilaczyńska-Cemel M; Krawiecka D
    Med Sci Monit; 2014 Nov; 20():2125-31. PubMed ID: 25362504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The analysis of smoking tobacco of patients with tuberculosis--data from ten years observation in Regional Center of Pulmonology in Bydgoszcz].
    Przybylski G; Dabrowska A; Gołda R; Gadzińska A; Trzcinska H
    Przegl Lek; 2012; 69(10):953-7. PubMed ID: 23421068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between smoking status, other factors and tuberculosis treatment failure in Morocco.
    Tachfouti N; Nejjari C; Benjelloun MC; Berraho M; Elfakir S; El Rhazi K; Slama K
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):838-43. PubMed ID: 21575308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [10 years comparative clinico-epidemiological analysis of smoking and alcohol consumption in TB patients (Myc. Tuberculosis) and with mycobacteriosis (Myc. Kansas].
    Przybylski G; Nowakowska-Arendt A; Pilaczyńska-Cemel M; Gołda R
    Przegl Lek; 2014; 71(11):576-80. PubMed ID: 25799847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South Africa.
    Peltzer K; Louw JS
    Afr Health Sci; 2014 Mar; 14(1):157-66. PubMed ID: 26060473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
    Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
    Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013-2021).
    Di Gennaro F; Lattanzio R; Guido G; Ricciardi A; Novara R; Patti G; Cotugno S; De Vita E; Brindicci G; Mariano MF; Ronga L; Santoro CR; Romanelli F; Stolfa S; Papagni R; Bavaro DF; De Iaco G; Saracino A
    Ann Glob Health; 2022; 88(1):26. PubMed ID: 35582409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug addiction and alcoholism as predictors for tuberculosis treatment default in Brazil: a prospective cohort study.
    Silva MR; Pereira JC; Costa RR; Dias JA; Guimarães MDC; Leite ICG
    Epidemiol Infect; 2017 Dec; 145(16):3516-3524. PubMed ID: 29173226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
    Sant Anna FM; Araújo-Pereira M; Schmaltz CAS; Arriaga MB; Andrade BB; Rolla VC
    PLoS One; 2023; 18(2):e0269765. PubMed ID: 36749743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study.
    Lorent N; Sebatunzi O; Mukeshimana G; Van den Ende J; Clerinx J
    PLoS One; 2011; 6(5):e19566. PubMed ID: 21611117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.